Bank of Montreal’s Biocept, Inc. BIOC Stock Holding History

Bank of Montreal’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,860	Closed	-$831K	–	3985
2021 Q3	$831K	Buy	+6,860	New	+$800K	﹤0.01%	2597
2019 Q2	–	Sell	-67	Closed	-$23K	–	5140
2019 Q1	$23K	Buy	+67	New	+$27.1K	﹤0.01%	3636
2017 Q4	–	Sell	-5	Closed	-$52K	–	4379
2017 Q3	$52K	Hold	5	–	–	﹤0.01%	3216
2017 Q2	$58K	Buy	+5	New	+$70.7K	﹤0.01%	3177
2015 Q2	–	Hold	0	–	-$22K	–	4162
2015 Q1	–	Hold	0	–	–	–	3242

Other funds holding BIOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of Montreal's BIOC Position: Q4 2021 in Review

Bank of Montreal sold out of Biocept, Inc. (BIOC) in Q4 2021, closing a stake of 6,860 shares — an estimated $831K sold.

Bank of Montreal first reported a position in BIOC in Q2 2017 and held it in 4 quarters. The position peaked at $831K in Q3 2021. 33 funds tracked by Wall St. Rank hold BIOC as of Q4 2021.

Bank of Montreal reported no remaining Biocept, Inc. position as of Q4 2021 after selling out during the quarter.
Bank of Montreal sold 6,860 Biocept, Inc. shares in Q4 2021, an estimated $831K.
Bank of Montreal first reported a position in Biocept, Inc. in Q2 2017 and held it in 4 quarters.
Bank of Montreal's Biocept, Inc. position peaked at $831K in Q3 2021.
33 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2021.

Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.